Incorporated in 2003, Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
Infinium Pharmachem’s manufacturing plant is located in Gujarat – INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.
The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.
Infinium Pharmachem IPO Details
| IPO Date | Mar 31, 2023 to Apr 5, 2023 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price | ₹135 per share |
| Lot Size | 1000 Shares |
| Total Issue Size | 1,875,000 shares (aggregating up to ₹25.26 Cr) |
| Fresh Issue | 1,875,000 shares (aggregating up to ₹25.26 Cr) |
| Employee Discount | Rs 13.5 per share |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
Infinium Pharmachem IPO Reservation
| Other Shares Offered | 0 (0.00%) |
| Other Shares Offered | 870,000 (50.00%) |
| Retail Shares Offered | 870,000 (50.00%) |
| Market Maker portion | 94,000 shares (SWASTIKA INVESTMART LIMITED) |
| Total Shares Offered | 1,740,000 |
Infinium Pharmachem IPO Tentative Timetable
Infinium Pharmachem IPO opens on Mar 31, 2023, and closes on Apr 5, 2023.
| Event | Tentative Date |
|---|---|
| Opening Date | Mar 31, 2023 |
| Closing Date | Apr 5, 2023 |
| Basis of Allotment | Apr 11, 2023 |
| Initiation of Refunds | Apr 12, 2023 |
| Credit of Shares to Demat | Apr 13, 2023 |
| Listing Date | Apr 17, 2023 |
| UPI Mandate Confirmation Cut-Off Time | 5.00 PM on the issue closing day |
Infinium Pharmachem IPO Lot Size
The Infinium Pharmachem IPO lot size is 1000 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1000 | ₹135,000 |
| Retail (Max) | 1 | 1000 | ₹135,000 |
| HNI (Min) | 2 | 2,000 | ₹270,000 |
| Lot Size Calculator |
Infinium Pharmachem IPO Promoter Holding
Mr. Sanjaykumar Viththalbhai Patel, Mr. Pravin Bhadabhai Madhani, and Mr. Mitesh Lavjibhai Chikhaliya are the company promoters.
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 73.05% |
Company Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Total Borrowing |
|---|---|---|---|---|---|
| 31-Mar-20 | 2,244.60 | 3,941.64 | 93.40 | 424.74 | 566.17 |
| 31-Mar-21 | 3,418.27 | 7,115.37 | 272.48 | 702.32 | 579.47 |
| 31-Mar-22 | 5,899.95 | 10,005.25 | 610.64 | 1,310.22 | 1,385.01 |
| 30-Sep-22 | 7,075.71 | 7,985.39 | 551.01 | 1,855.77 | 1,614.71 |
| Amount in ₹ Lakhs |
Objects of the Issue
The proceeds from the fresh issue will be utilized for the following objects:
1. Marketing and branding expenses (including registration in reach – Europe, and other marketing expenses).
2. Repayment of some of the existing loans and expansion of units.
3. To meet incremental working capital requirements.
4. To meet public issue expenses.
Infinium Pharmachem IPO Review (May apply)
[Dilip Davda] IPL is in the pharma and healthcare segment and has posted growth in its top and bottom lines for the reported periods. Super earnings for FY23 H1 raise eyebrows and concern over the sustainability of such margins going forward. Well-informed investors may park funds for medium to long-term rewards. Read detail review…
Infinium Pharmachem IPO Subscription Status (Bidding Detail)
The Infinium Pharmachem IPO is subscribed 0.08 times on Mar 31, 2023 7:30:00 PM. The public issue subscribed 0.10 times in the retail category, times in the QIB category, and 0.06 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| Other | 0.06 |
| Retail | 0.10 |
| Total | 0.08 |
Total Application : 88 (0.09 times)
Infinium Pharmachem IPO Key Performance Indicator
| KPI | Values |
|---|---|
| P/E (x) | 7.83 |
| Market Cap (₹ Cr.) | 93.93 |
Infinium Pharmachem IPO Prospectus
Company Contact Information
Infinium Pharmachem Limited
38 G.I.D.C Sojitra,
Taluka – Sojitra,
Dist. – Anand – 387240
Phone: +91-2692-238849
Email: info@infiniumpharmachem.com
Website: https://infiniumpharmachem.com/
Infinium Pharmachem IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://www.bigshareonline.com/